Cargando…
The Role of Immunosuppression in the Development of COVID-19 in Systemic Lupus Erythematosus Patients: A Brief Report
Recently, due to the coronavirus disease 2019 (COVID-19) pandemic, much concern has been raised about patients with chronic diseases who may become more susceptible to the disease. The present cross-sectional study aimed to characterize the clinical course of COVID-19 in patients with systemic lupus...
Autores principales: | Damirchi, Mohammadrafi, Aghaie, Mehrdad, Sedighi, Sima, Tavassoli, Samaneh, Roshandel, Gholamreza, Hassani, Mohammadjavad, Abdolahi, Nafiseh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843453/ https://www.ncbi.nlm.nih.gov/pubmed/36688192 http://dx.doi.org/10.30476/ijms.2022.94402.2565 |
Ejemplares similares
-
Cytomegalovirus retinitis in a seronegative patient with systemic lupus erythematosus on immunosuppressive therapy
por: Kelkar, Aditya, et al.
Publicado: (2011) -
IL-17 is Aberrantly Overexpressed Among Under-treatment Systemic Lupus Erythematosus Patients
por: Mohammadi, Saeed, et al.
Publicado: (2019) -
Brief report: Decreased expression of CD244 (SLAMF4) on monocytes and platelets in patients with systemic lupus erythematosus
por: Mak, Anselm, et al.
Publicado: (2017) -
Factors Associated with Outcome in Patients with Acute Upper Gastrointestinal Bleeding in a Tertiary Referral Center in Northern Iran
por: Baradaran, Fatemeh, et al.
Publicado: (2016) -
Brain paracoccidioidomycosis in an immunosuppressed patient with systemic lupus erythematosus
por: Kamer, Carolina, et al.
Publicado: (2021)